Avanafil is a whole new medication during the phosphodiesterase variety 5 inhibitor class. The suppliers decide to sector avanafil as the first agent in the 2nd era of the class with a more rapid onset and an even better side influence profile. It is apparent that avanafil is efficient to the remedy